España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Eagle Pharmaceuticals
EGRX
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.5500
-0.05
-8.33%
At close: -
Get Report
Comment
Eagle Pharmaceuticals (EGRX) Forecast
News
Earnings
Eagle Pharmaceuticals (EGRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Eagle Pharmaceuticals (OTC:EGRX) Stock
Eagle Pharmaceuticals Stock (OTC: EGRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, October 02, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Crude Oil Edges Higher; ConAgra Posts Downbeat Earnings
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Dow Gains 100 Points; Joby Aviation Shares Spike Higher
Avi Kapoor
US Stocks Edge Lower; Private Employment Beats Expectations
Avi Kapoor
Eagle Pharmaceuticals Shares Resume Trade
Benzinga Newsdesk
Eagle Pharmaceuticals Shares Halted On Circui...
Benzinga Newsdesk
Eagle Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
Eagle Pharmaceuticals To Be Delisted From Nas...
Benzinga Newsdesk
Tuesday, August 27, 2024
Eagle Pharmaceuticals Receives Delisting Noti...
Benzinga Newsdesk
Wednesday, July 10, 2024
Eagle Pharmaceuticals TO Pay Curia $26.5M, Wi...
Benzinga Newsdesk
Wednesday, May 22, 2024
Eagle Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Eagle Pharmaceuticals Announces Nasdaq Delist...
Benzinga Newsdesk
Tuesday, April 30, 2024
Eagle Pharmaceuticals Announces A Trial In Pr...
Benzinga Newsdesk
Monday, April 15, 2024
Eagle Pharmaceuticals To Present Additional D...
Benzinga Newsdesk
Friday, April 12, 2024
Eagle Pharmaceuticals Announces Receipt Of No...
Benzinga Newsdesk
Thursday, January 18, 2024
Eagle Pharmaceuticals Provides Update on Bend...
Benzinga Newsdesk
Wednesday, December 06, 2023
Eagle Pharmaceuticals To Present Abstract On ...
Benzinga Newsdesk
Thursday, November 30, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, November 29, 2023
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Why Is Eagle Pharmaceuticals Stock Trading Lower Today?
Vandana Singh
Eagle Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Eagle Pharmaceuticals Receives Notification o...
Benzinga Newsdesk
Eagle Pharmaceuticals Says Effective Immediat...
Benzinga Newsdesk
Friday, November 17, 2023
Top 4 Health Care Stocks That Could Blast Off This Quarter
Lisa Levin
Tuesday, November 14, 2023
Earnings Scheduled For November 14, 2023
Benzinga Insights
Monday, November 13, 2023
Eagle Pharmaceuticals's Earnings: A Preview
Benzinga Insights
Thursday, November 09, 2023
Eagle Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
Eagle Pharmaceuticals Delays Q3 2023 Results ...
Benzinga Newsdesk
Wednesday, November 01, 2023
Board Member at Eagle Pharmaceuticals Exercises Options Worth $128K
Benzinga Insights
Tuesday, October 24, 2023
Eagle Pharmaceuticals Granted Patent For PEMF...
Benzinga Newsdesk
Monday, October 23, 2023
Eagle Pharmaceuticals Says Granted Unique J-C...
Benzinga Newsdesk
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, September 11, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, September 08, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Tuesday, August 29, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Eagle Pharmaceuticals Announced A Type C Meet...
Benzinga Newsdesk
Thursday, August 17, 2023
Eagle Pharmaceuticals Reiterates Its Previous...
Benzinga Newsdesk
Wednesday, August 09, 2023
Piper Sandler Downgrades Eagle Pharmaceutical...
Benzinga Newsdesk
Tuesday, August 08, 2023
Eagle Pharmaceuticals Reiterates FY23 Adjuste...
Benzinga Newsdesk
Eagle Pharmaceuticals Q2 Adjusted EPS $1.18 B...
Benzinga Newsdesk
Earnings Scheduled For August 8, 2023
Benzinga Insights
Monday, August 07, 2023
Earnings Outlook For Eagle Pharmaceuticals
Benzinga Insights
Monday, July 31, 2023
Eagle Pharmaceuticals Boosts 2023 Adjusted EP...
Benzinga Newsdesk
Monday, July 24, 2023
Eagle Pharmaceuticals Announced That The Firs...
Benzinga Newsdesk
Show More